Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
18.07%
Operating Margin
6.78%
Net Margin
-2.90%
Efficiency Metrics
Revenue per Expense Ratio
1.07
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
1.97%
Income Tax Rate
-3,660,000,000.0%
EPS
-1.0000000000
Balance Sheet Analysis
Current Ratio
1.49
Cash Ratio
0.29
Working Capital
$618.80M
Debt to Equity
1.65
Debt to Assets
47.37%
Equity Ratio
28.77%
Cash Flow Analysis
Operating Cash Flow Ratio
10.52%
Free Cash Flow Ratio
8.11%
CapEx to Revenue
2.41%
Dividends Paid
$239.40M
Stock Buybacks
$6.00M
Total Shareholder Returns
$245.40M
Cash Position Change
15.48%
Key Takeaways (2023 FY)
Revenue declined by 8.1877708045932%, indicating potential market challenges
Increased dividend payments by 4.30%
Detailed Growth Metrics
Core Performance
Revenue
-8.19%
Net Income
-144.16%
EPS
-143.86%
Operating Income
-33.90%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
8.92%
Operating Cash Flow
12.64%
Free Cash Flow
12.40%
Balance Sheet Health
Assets
-10.64%
Debt
-3.99%
Book Value per Share
-18.85%
Inventory
-9.67%
Shareholder Returns
Dividends per Share
4.30%
Shares Outstanding
0.15%
Long Term Trends
3Y Revenue/Share
9.91%
5Y Revenue/Share
9.05%
3Y Dividend/Share
12.69%
5Y Dividend/Share
21.78%